Literature DB >> 25691668

Can money really be no object when cancer care is the subject?

Leonard B Saltz1.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 25691668     DOI： 10.1200/JCO.2014.60.1401

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  9 in total

Review 1.  Value in Colorectal Cancer Treatment: Where It Is Lacking, and Why.

Authors:  Leonard B Saltz
Journal:  Cancer J       Date:  2016 May-Jun       Impact factor: 3.360

2.  Cost description of chemotherapy regimens for the treatment of metastatic pancreas cancer.

Authors:  Daniel A Goldstein; Kavya Krishna; Christopher R Flowers; Bassel F El-Rayes; Tanios Bekaii-Saab; Anne M Noonan
Journal:  Med Oncol       Date:  2016-04-11       Impact factor: 3.064

3.  Cost-Effectiveness Analysis of Regorafenib for Metastatic Colorectal Cancer.

Authors:  Daniel A Goldstein; Bilal B Ahmad; Qiushi Chen; Turgay Ayer; David H Howard; Joseph Lipscomb; Bassel F El-Rayes; Christopher R Flowers
Journal:  J Clin Oncol       Date:  2015-08-24       Impact factor: 44.544

Review 4.  Metastatic Colorectal Cancer: A Systematic Review of the Value of Current Therapies.

Authors:  Daniel A Goldstein; Simon B Zeichner; Catherine M Bartnik; Eli Neustadter; Christopher R Flowers
Journal:  Clin Colorectal Cancer       Date:  2015-10-22       Impact factor: 4.481

5.  Acquired resistance to immunotherapy and future challenges.

Authors:  Nicholas P Restifo; Mark J Smyth; Alexandra Snyder
Journal:  Nat Rev Cancer       Date:  2016-02       Impact factor: 60.716

6.  Low-value practices in oncology contributing to financial toxicity.

Authors:  Bishal Gyawali
Journal:  Ecancermedicalscience       Date:  2017-03-16

7.  Cost-Effectiveness Analysis of First-Line FOLFIRI Combined With Cetuximab or Bevacizumab in Patients With RAS Wild-Type Left-Sided Metastatic Colorectal Cancer.

Authors:  Jiaqi Han; Desheng Xiao; Chongqing Tan; Xiaohui Zeng; Huabin Hu; Shan Zeng; Qin Jiang; Longjiang She; Linli Yao; Li Li; Lanhua Tang; Jian Ma; Jin Huang; Liangfang Shen
Journal:  Cancer Control       Date:  2020 Jan-Dec       Impact factor: 3.302

8.  Health Care Spending: Changes in the Perceptions of the Australian Public.

Authors:  Jane Robertson; David A Newby; Emily J Walkom
Journal:  PLoS One       Date:  2016-06-13       Impact factor: 3.240

9.  Half-dose fulvestrant plus anastrozole as a first-line treatment for hormone receptor-positive metastatic breast cancer: a cost-effectiveness analysis.

Authors:  Xiaoting Huang; Xiuhua Weng; Shen Lin; Yiwei Liu; Shaohong Luo; Hang Wang; Wai-Kit Ming; Pinfang Huang
Journal:  BMJ Open       Date:  2020-08-30       Impact factor: 2.692
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.